Evidence map›Paper›PMID 36307399›Full record

Trial reportBlood cancer journal2022

High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study.

Jun Li, Qi Han, Yanqing Huang, Yanhui Wei, Jie Zi, Lidong Zhao, Zhimei Cai, Xuzhang Lu, Rong Xiao, Yanming Zhang and 25 more

Abstract readClinical Trial, Phase IILetter
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Blood cancer journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Jun Li *Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing, China.
Qi Han *Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing, China.
Yanqing Huang *Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing, China.
Yanhui WeiDepartment of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing, China.
Jie ZiDepartment of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing, China.
Lidong ZhaoDepartment of Hematology, The First People's Hospital of Lianyungang, Lianyungang, China.
Zhimei CaiDepartment of Hematology, The First People's Hospital of Lianyungang, Lianyungang, China.
Xuzhang LuDepartment of Hematology, Changzhou No.2 People's Hospital, Changzhou, China.
Rong XiaoDepartment of Hematology, Changzhou No.2 People's Hospital, Changzhou, China.
Yanming ZhangDepartment of Hematology, Huai'an Second People's Hospital, Huai'an, China.
Xiaotian YangDepartment of Hematology, Huai'an Second People's Hospital, Huai'an, China.
Hao XuDepartment of Hematology, Yancheng No.1 People's Hospital, Yancheng, China.
Naitong SunDepartment of Hematology, Yancheng Third People's Hospital, Yancheng, China.
Wanchuan ZhuangDepartment of Hematology, The Second People's Hospital of Lianyungang, Lianyungang, China.
Zhengdong WuDepartment of Hematology, Jiangsu Taizhou People's Hospital, Taizhou, China.
Yuan XiaDepartment of Hematology, Jiangsu Taizhou People's Hospital, Taizhou, China.
Yanli XuDepartment of Hematology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Bin HeDepartment of Hematology, Northern Jiangsu People's Hospital, Yangzhou, China.
Wei ZhuDepartment of Hematology, Xuzhou No. 1 People's Hospital, Xuzhou, China.
Fengling MinDepartment of Hematology, Affiliated Hospital of Yangzhou University, Yangzhou, China.
Yongchun ChenDepartment of Hematology, Affiliated Hospital of Yangzhou University, Yangzhou, China.
Banghe DingDepartment of Hematology, Huai'an First People's Hospital, Huai'an, China.
Peimin ShiDepartment of Hematology, Taixing People's Hospital, Taizhou, China.
Jing XieDepartment of Hematology, Taixing People's Hospital, Taizhou, China.
Hua TangDepartment of Hematology, Xinghua City People's Hospital, Taizhou, China.
Zefa LiuDepartment of Hematology, Xinghua City People's Hospital, Taizhou, China.
Bingzong LiDepartment of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Yu SunDepartment of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Hongxia QiuDepartment of Geriatric Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Limin DuanDepartment of Geriatric Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Elanora DovatHershey Medical Center, Pennsylvania State University Medical College, Hershey, PA, USA.
Chunhua SongHershey Medical Center, Pennsylvania State University Medical College, Hershey, PA, USA. chunhua.song@osumc.edu.
Laszlo SzeKelyDepartment of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Department of Laboratory Medicine, Division of Pathology, Karolinska Institute, Stockholm, Sweden.
Sinisa DovatHershey Medical Center, Pennsylvania State University Medical College, Hershey, PA, USA.ORCID 0000-0003-3906-6165
Zheng GeDepartment of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing, China. zhengge@seu.edu.cn.ORCID 0000-0001-8028-1612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesAntineoplastic Combined Chemotherapy ProtocolsAzacitidineHumansTreatment OutcomeAzacitidine

Identifiers

PMID36307399
PMCPMC9616883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.